Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank. — CFSMEATLAS
Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.
Domingues, Tiago Dias, Grabowska, Anna D, Lee, Ji-Sook et al. · Frontiers in medicine · 2021 · DOI
Quick Summary
This study looked at whether common herpes viruses (like the ones that cause cold sores and chickenpox) are connected to ME/CFS, and whether different groups of patients—based on what triggered their illness—have different patterns of virus exposure. Researchers tested blood samples from ME/CFS patients and healthy people to see if they had antibodies to these viruses. They found some differences between patient groups, but the results were weak and inconsistent depending on how they analyzed the data.
Why It Matters
ME/CFS patients and their clinicians have long suspected that persistent herpesvirus infections may contribute to the disease. This study is important because it shows that different subgroups of ME/CFS patients—particularly those whose illness was triggered by a confirmed infection—may have different immune responses to these viruses, which could eventually help identify ME/CFS subtypes and guide treatment decisions.
Observed Findings
Patients with non-infection triggers (S₁) showed lower seropositivity to Epstein-Barr virus (VCA and EBNA1 antigens) and Varicella-Zoster virus compared to healthy controls using specific cutoff values.
Patients with lab-confirmed infection triggers (S₃) had lower seroprevalence to human cytomegalovirus across all seropositivity cutoffs compared to healthy controls.
Herpesvirus serology patterns differed between the four patient subgroups stratified by disease trigger type.
Statistical significance of findings varied substantially depending on which multiple testing correction procedure was applied (Benjamini-Hochberg versus Benjamini-Yekutieli).
Inferred Conclusions
Herpesvirus serology may be useful in distinguishing different subgroups of ME/CFS patients based on their reported disease triggers.
The relationship between herpesvirus exposure and ME/CFS appears to be heterogeneous, suggesting that different patients may have different underlying viral associations.
The inconsistency of results across different statistical methods highlights the need for more rigorous study designs and pre-registered analytical approaches in herpesvirus-ME/CFS research.
Remaining Questions
Do these observed differences in herpesvirus serology patterns have any functional or clinical significance, or are they statistical artifacts?
Why do patients with confirmed infection triggers show lower CMV seroprevalence rather than higher—what could explain this unexpected finding?
What This Study Does Not Prove
This study does not prove that herpesviruses cause ME/CFS or that they drive the illness in most patients. The findings are statistically weak and depend heavily on which statistical methods and cutoff values are used, meaning they may not hold up with different analytical approaches. The cross-sectional design cannot establish causation—even if herpesvirus serology patterns differ, this does not demonstrate that the viruses cause ME/CFS.
Tags
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionSmall SampleExploratory OnlyMixed Cohort
Would prospective studies or functional immune assays (rather than serology alone) reveal clearer causal links between herpesviruses and ME/CFS in these subgroups?
Can these serological patterns help predict clinical outcomes, disease severity, or treatment response in ME/CFS patients?